Severe orbital inflammation and hemorrhage complicating bleomycin sclerotherapy for orbital lymphaticovenous malformation

References

• Issva.org. 2021. Classification - International Society for the study of vascular anomalies. [online]. Accessed 22 April 2021. Available at: <https://www.issva.org/classification>
   Google Scholar
• Shiels WE 2nd, Kang DR, Murakami JW, Hogan MJ, Wiet GJ. Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg. 2009;141(2):219–224. doi:10.1016/j.otohns.2009.04.001.
   PubMed Web of Science ®Google Scholar
• Lally S. Update on orbital lymphatic malformations. Curr Opin Ophthalmol. 2016;27(5):413–415. doi:10.1097/icu.0000000000000291.
   PubMed Web of Science ®Google Scholar
• Raichura N, Alam M, Noronha V, Mukherjee B. A prospective study of the role of intralesional bleomycin in orbital lymphangioma. J AAPOS. 2017;21(2):146–151. doi:10.1016/j.jaapos.2017.03.007.
   PubMed Web of Science ®Google Scholar
• Nassiri N, Rootman J, Rootman D, Goldberg R. Orbital lymphaticovenous malformations: current and future treatments. Surv Ophthalmol. 2015;60(5):383–405. doi:10.1016/j.survophthal.2015.03.001.
   PubMed Web of Science ®Google Scholar
• Tunc M, Sadri E, Char D. Orbital lymphangioma: an analysis of 26 patients. British J Ophthalmol. 1999;83(1):76–80. doi:10.1136/bjo.83.1.76.
   PubMed Web of Science ®Google Scholar
• Harris G, Sakol P, Bonavolontà G, De Conciliis C. An analysis of thirty cases of orbital lymphangioma. Ophthalmology. 1990;97(12):1583–1592. doi:10.1016/s0161-6420(90)32370-9.
   PubMed Web of Science ®Google Scholar
• Shields J, Shields C, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions. Ophthalmology. 2004;111(5):997–1008. doi:10.1016/j.ophtha.2003.01.002.
   PubMed Web of Science ®Google Scholar
• Greene AK, Burrows PE, Smith L, Mulliken JB. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg. 2005;115:22–30.
   PubMed Web of Science ®Google Scholar
• Patel SR, Rosenberg JB, Barmettler A. Interventions for orbital lymphangioma. Cochrane Database Syst Rev. 2019;5(5):CD013000. Published 2019 May 15. doi:10.1002/14651858.CD013000.pub2.
   PubMedGoogle Scholar
• Barnacle AM, Theodorou M, Maling SJ, Abou-Rayyah Y. Sclerotherapy treatment of orbital lymphatic malformations: a large single-centre experience. Br J Ophthalmol. 2016;100(2):204–208. doi:10.1136/bjophthalmol-2015-306657.
   PubMed Web of Science ®Google Scholar
• Abdelaziz O, Hassan F, Elessawy K, Emad-Eldin S, Essawy RE. Image-guided percutaneous bleomycin and bevacizumab sclerotherapy of orbital lymphatic malformations in children. Cardiovasc Intervent Radiol. 2019;42(3):433–440. doi:10.1007/s00270-018-2128-4.
   PubMed Web of Science ®Google Scholar
• Bothra N, Panda L, Sheth J, Tripathy D. Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations. Eye (Lond). 2018;32(1):152–155. doi:10.1038/eye.2017.154.
   PubMed Web of Science ®Google Scholar
• Colletti G, Deganello A, Bardazzi A, Mattassi R, Dalmonte P, Gazzabin L, et al. Complications after treatment of head and neck venous malformations with sodium tetradecyl sulfate foam. J Craniofac Surg. 2017;28(4):e388–92. doi:10.1097/SCS.0000000000003723.
   PubMed Web of Science ®Google Scholar
• De Maria L, De Sanctis P, Tollefson M, Mardini S, Garrity JA, Morris PP, et al. Sclerotherapy for low-flow vascular malformations of the orbital and periocular regions: systematic review and meta-analysis. Surv Ophthalmol. 2020;65(1):41–47. doi:10.1016/j.survophthal.2019.08.003.
   PubMed Web of Science ®Google Scholar
• Nuruddin M, Roy SR, Mudhar HS. Results of intralesional bleomycin sclerotherapy for treatment of orbital lymphangiomas at a tertiary eye care centre in Bangladesh. Ocul Oncol Pathol. 2019;5(6):412–417. doi:10.1159/000495248.
   PubMed Web of Science ®Google Scholar
• MacIntosh PW, Yoon MK, Fay A. Complications of intralesional bleomycin in the treatment of orbital lymphatic malformations. Semin Ophthalmol. 2014;29(5–6):450–455. doi:10.3109/08820538.2014.959617.
   PubMed Web of Science ®Google Scholar
• Schwarcz RM, Ben Simon GJ, Cook T, Goldberg RA. Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit. Am J Ophthalmol. 2006;141(2):333–339. doi:10.1016/j.ajo.2005.09.026.
   PubMed Web of Science ®Google Scholar
• Prat D, Gomel N, Zloto O, Anne M, BenSaid A, Bhattacharjee K, et al. Low-dose bleomycin injections for orbital lymphatic and lymphatic-venous malformations. Ophthalmic Plast Reconstr Surg. 2020 Nov 5. doi:10.1097/IOP.0000000000001870.
   Web of Science ®Google Scholar
• Hanif AM, Saunders JA, Hawkins CM, Wojno TH, Kim HJ. Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations. Orbit. 2019;38(1):30–36. doi:10.1080/01676830.2018.1480636.
   PubMed Web of Science ®Google Scholar
• Chiramel GK, Keshava SN, Moses V, Mammen S, David S, Sen S. Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit. Cardiovasc Intervent Radiol. 2015;38(2):270–279. doi:10.1007/s00270-014-0971-5.
   PubMed Web of Science ®Google Scholar
• Harmoush S, Chinnadurai P, El Salek K, Metwalli Z, Herce H, Bhatt A, et al. Multimodality image-guided sclerotherapy of low-flow orbital vascular malformations: report of single-center experience. J Vasc Interv Radiol. 2016;27(7):987–995.e4.doi:10.1016/j.jvir.2016.02.036.
   PubMed Web of Science ®Google Scholar
• Svendsen PA, Wikholm G, Rodriguez M, Enoksson P, Frisén L, Strömland K, et al. Direct puncture and sclerotherapy with sotradecol ((r)). Orbital lymphatic malformations. Interv Neuroradiol. 2001;7(3):193–199.doi:10.1177/159101990100700303.
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Weingeist TA. Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia. Br J Ophthalmol. 1980;64(11):818–825. doi:10.1136/bjo.64.11.818.
   PubMed Web of Science ®Google Scholar
• McCallum E, Keren S, Lapira M, Norris JH. Orbital compartment syndrome: an update with review of the literature. Clin Ophthalmol. 2019;13:2189–2194. doi:10.2147/OPTH.S180058.
   PubMed Web of Science ®Google Scholar
• Bailey LA, van Brummen AJ, Ghergherehchi LM, Chuang AZ, Richani K, Phillips ME. Visual OUTCOMES OF PATIENTS WITH RETROBULBAR HEMORRHAGE UNDERGOING LATERAL CANTHOTOMY AND CANTholysis. Ophthalmic Plast Reconstr Surg. 2019;35(6):586–589. doi:10.1097/IOP.0000000000001401.
   PubMed Web of Science ®Google Scholar
• Ujam A, Perry M. Emergency management for orbital compartment syndrome-is decompression mandatory? Int J Oral Maxillofac Surg. 2016;45(11):1435–1437. doi:10.1016/j.ijom.2016.08.001.
   PubMed Web of Science ®Google Scholar